FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose

View source ↗

Summary

FDA approves another OTC naloxone nasal spray (Rextovy) for emergency treatment of opioid overdose, expanding access.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• REXTOVY (Naloxone hydrochloride)

Snippet

The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.